P1.13A.09 RYZ101 (225Ac-DOTATATE) + Carboplatin + Etoposide + Atezolizumab in Somatostatin Receptor Expressing Extensive-Stage Small-Cell Lung Cancer

• DOI: 10.1016/j.jtho.2024.09.378
• Publication Date: 2024-10-16T02:44:22Z
• Authors: S. Puri; W. Akerley; R. Langdon; S. Mehr; N. Rivera-Rodriguez; J. Berilgen; J.M. Rineer; C. Mulvey; K. Howell; A.S. Mansfield; E. Parent; M. Thakur; B. Mancini; J. Goldman; J. Calais; D. Bushnell; Y. Yuan; J. Li; N. Pascale; L. Gong; D. Ferreira; Z. Hao
• Keywords: Atezolizumab; Carboplatin